Records collected on Monday, April 20, 2026

22 records, grouped by source. Every entry links to the official source.

← Apr 19, 2026 · Apr 21, 2026 →

Company filings on SEC EDGAR 1

• INTELLIGENT BIO SOLUTIONS INC. Apr 20, 2026 · Form 8-K (company current report)

U.S. Food and Drug Administration 20

• FDA Class II: Fagron Compounding Services — Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Servic Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL fre Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Teva Pharmaceuticals USA, Inc — Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freef Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Teva Pharmaceuticals USA, Inc — Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fagron Compounding Services — Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Servi Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freefle Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: GE Healthcare Ireland Limited — GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthca Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Cipla USA, Inc. — Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, M Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Teva Pharmaceuticals USA, Inc — Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fagron Compounding Services — norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Service Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Freseni Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Fresenius Kabi USA, LLC — 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freef Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Viatris, Inc. — Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: V Apr 15, 2026 · FDA enforcement report entry
• FDA Class II: Preferred Pharmaceuticals, Inc. — Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%) Apr 15, 2026 · FDA enforcement report entry

Federal and state courts (via CourtListener) 1

• The Bridge Strategy & Technology Consulting, LLC v. Josh Adams Apr 16, 2026 · Court opinion